Storia in 3 fonti

Weight loss drugs show signs of slowing biological aging, scientists discover

GLP-1 drugs help fight the harmful inflammation that raises the risk of chronic disease

Raccontata da

independent.co.uk

forbes.com

fightaging.org

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

independent.co.ukStai leggendo1 mese fa

Weight loss drugs show signs of slowing biological aging, scientists discover

GLP-1 drugs help fight the harmful inflammation that raises the risk of chronic disease

originale

fightaging.org1 mese fa

GLP-1 Receptor Agonists Slow Epigenetic Aging, a Measure of the Harms Done by Excess Visceral Fat

Weight loss drugs are a major focus of the pharmaceutical industry at present. It remains to be seen as to what will emerge as the next big class of weight loss drugs following GLP-1 receptor agonists. Since the primary…

Leggi questa versione → originale

Timeline cronologica

venerdì 12 giugno 2026·independent.co.uk
Weight loss drugs show signs of slowing biological aging, scientists discover
GLP-1 drugs help fight the harmful inflammation that raises the risk of chronic disease
sabato 13 giugno 2026·forbes.com
GLP-1 Drugs May Protect Against Cancer— Here’s What That Means For Public Health
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.

Weight loss drugs show signs of slowing biological aging, scientists discover

GLP-1 Receptor Agonists Slow Epigenetic Aging, a Measure of the Harms Done by Excess Visceral Fat

Timeline cronologica

Weight loss drugs show signs of slowing biological aging, scientists discover

GLP-1 Drugs May Protect Against Cancer— Here’s What That Means For Public Health

GLP-1 Drugs May Protect Against Cancer— Here’s What That Means For Public Health

GLP-1 Receptor Agonists Slow Epigenetic Aging, a Measure of the Harms Done by Excess Visceral Fat